These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23926691)

  • 1. Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jun; 51(6):435-43. PubMed ID: 23926691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-depressant-like activity of a novel serotonin type-3 (5-HT3) receptor antagonist in rodent models of depression.
    Gupta D; Devadoss T; Bhatt S; Gautam B; Jindal A; Pandey D; Mahesh R
    Indian J Exp Biol; 2011 Aug; 49(8):619-26. PubMed ID: 21870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
    Kumar B; Jindal A; Pandey DK; Bhatt S; Devadoss T; Mahesh R
    Indian J Exp Biol; 2012 Sep; 50(9):625-32. PubMed ID: 23140020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.
    Bhatt S; Mahesh R; Devadoss T; Jindal AK
    Indian J Pharmacol; 2013; 45(4):348-53. PubMed ID: 24014909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression.
    Devadoss T; Pandey DK; Mahesh R; Yadav SK
    Pharmacol Rep; 2010; 62(2):245-57. PubMed ID: 20508279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.
    Pandey DK; Rajkumar R; Mahesh R; Radha R
    J Pharm Pharmacol; 2008 Dec; 60(12):1643-50. PubMed ID: 19000369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.
    Pandey DK; Devadoss T; Modak N; Mahesh R
    Indian J Med Res; 2016 Oct; 144(4):614-621. PubMed ID: 28256473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT₃ receptor antagonist in behaviour based rodent models: evidence for the involvement of serotonergic system.
    Gautam BK; Jindal A; Dhar AK; Mahesh R
    Pharmacol Biochem Behav; 2013 Aug; 109():91-7. PubMed ID: 23680574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
    Rajkumar R; Pandey DK; Mahesh R; Radha R
    Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
    Mahesh R; Rajkumar R; Minasri B; Venkatesha Perumal R
    Pharmazie; 2007 Dec; 62(12):919-24. PubMed ID: 18214343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
    Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
    J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R; Radhakrishnan M; Borah M
    Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
    Kurhe Y; Mahesh R; Devadoss T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
    Dhar AK; Mahesh R; Jindal A; Bhatt S
    Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.